Does transcatheter tricuspid edge-to-edge repair (T-TEER) improve mortality and perioperative outcomes compared to surgical repair in Medicare beneficiaries with tricuspid regurgitation?
In Medicare beneficiaries with tricuspid regurgitation, T-TEER offers comparable 2-year mortality to surgical repair with better perioperative safety, though it carries a higher risk of subsequent valve reintervention.
Among Medicare beneficiaries with TR, the 2-year mortality rate was comparable between T-TEER and surgical repair. T-TEER showed advantages in perioperative outcomes, including lower in-hospital mortality and pacemaker implantation rates, whereas tricuspid valve reinterventions were more frequent in the T-TEER group. Further studies are necessary to refine indications, patient selections, and optimal timing for intervention with either treatment strategy.
Shimoda et al. (Mon,) studied this question.